{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T20:43:34Z","timestamp":1771706614200,"version":"3.50.1"},"reference-count":22,"publisher":"Japan Neurosurgical Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2017]]},"DOI":"10.2176\/nmc.st.2016-0153","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T22:06:51Z","timestamp":1483654011000},"page":"66-72","source":"Crossref","is-referenced-by-count":3,"title":["Proposal for a Prospective Registry for Moyamoya Disease in Japan"],"prefix":"10.2176","volume":"57","author":[{"given":"Ken","family":"KAZUMATA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"ITO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruto","family":"UCHINO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"NISHIHARA","sequence":"additional","affiliation":[{"name":"Translational Research Laboratory, Hokkaido University Hospital, Clinical Research and Medical Innovation Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohiro","family":"HOUKIN","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mizushima H, Tanabe M, Kanatani Y: Patient database and orphan drug development. <i>Yakugaku Zasshi<\/i> 134: 599\u2013605, 2014 (Japanese)","DOI":"10.1248\/yakushi.13-00256-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fujimura M, Tominaga T: Diagnosis of moyamoya disease: international standard and regional differences. <i>Neurol Med Chir<\/i> (<i>Tokyo<\/i>) 55: 189\u2013193, 2015","DOI":"10.2176\/nmc.ra.2014-0307"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A: Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. <i>Neurol Med Chir<\/i> (<i>Tokyo<\/i>) 52: 299\u2013303, 2012","DOI":"10.2176\/nmc.52.299"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, Taura D, Sone M, Asaka I, Ameku T, Watanabe A, Kasahara T, Sudo T, Shiota F, Hashikata H, Takagi Y, Morito D, Miyamoto S, Nakao K, Koizumi A: Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G&gt;A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. <i>Biochem Biophys Res Commun<\/i> 438: 13\u201319, 2013","DOI":"10.1016\/j.bbrc.2013.07.004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ito A, Fujimura M, Niizuma K, Kanoke A, Sakata H, Morita-Fujimura Y, Kikuchi A, Kure S, Tominaga T: Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease. <i>Brain Res<\/i> 1594: 310\u2013320, 2015","DOI":"10.1016\/j.brainres.2014.11.014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kobayashi H, Matsuda Y, Hitomi T, Okuda H, Shioi H, Matsuda T, Imai H, Sone M, Taura D, Harada KH, Habu T, Takagi Y, Miyamoto S, Koizumi A: Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of Moyamoya disease, in angiogenesis <i>in vitro<\/i> and <i>in vivo<\/i>. <i>J Am Heart Assoc<\/i> 4: e002146, 2015","DOI":"10.1161\/JAHA.115.002146"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fujimura M, Tominaga T: Diagnosis of moyamoya disease: international standard and regional differences. <i>Neurol Med Chir<\/i> (<i>Tokyo<\/i>) 55: 189\u2013193, 2015","DOI":"10.2176\/nmc.ra.2014-0307"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Dai D, Lu Q, Huang Q, Yang P, Hong B, Xu Y, Zhao W, Liu J, Li Q: Serum miRNA signature in Moyamoya disease. <i>PLoS One<\/i> 9: e102382, 2014","DOI":"10.1371\/journal.pone.0102382"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S: A new horizon of moyamoya disease and associated health risks explored through RNF213. <i>Environ Health Prev Med<\/i> 21: 55\u201370, 2016","DOI":"10.1007\/s12199-015-0498-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zhao S, Gong Z, Zhang J, Xu X, Liu P, Guan W, Jing L, Peng T, Teng J, Jia Y: Elevated Serum MicroRNA Let-7c in Moyamoya disease. <i>J Stroke Cerebrovasc Dis<\/i> 24: 1709\u20131714, 2015","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.01.041"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kuroda S; AMORE Study Group: Asymptomatic moyamoya disease: literature review and ongoing AMORE study. <i>Neurol Med Chir (Tokyo)<\/i> 55: 194\u2013198, 2015","DOI":"10.2176\/nmc.ra.2014-0305"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC; JAM Trial Investigators: Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. <i>Stroke<\/i> 45: 1415\u20131421, 2014","DOI":"10.1161\/STROKEAHA.113.004386"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Takagi Y, Miyamoto S; COSMO-Japan Study Group: Cognitive Dysfunction Survey of the Japanese Patients with Moyamoya Disease (COSMO-JAPAN Study): study protocol. <i>Neurol Med Chir (Tokyo)<\/i> 55: 199\u2013203, 2015","DOI":"10.2176\/nmc.ra.2014-0326"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Thompson R, Johnston L, Taruscio D, Monaco L, B\u00e9roud C, Gut IG, Hansson MG, &apos;t Hoen PB, Patrinos GP, Dawkins H, Ensini M, Zatloukal K, Koubi D, Heslop E, Paschall JE, Posada M, Robinson PN, Bushby K, Lochm\u00fcller H: RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. <i>J Gen Intern Med<\/i> 29 Suppl 3: S780\u2013S787, 2014","DOI":"10.1007\/s11606-014-2908-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bersano A, Guey S, Bedini G, Nava S, Herv\u00e9 D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJ, Braun KP, Kronenburg A, Acerbi F, Brown MM, Calviere L, Cordonnier C, Henon H, Thines L, Khan N, Czabanka M, Kraemer M, Simister R, Prontera P, Tournier-Lasserve E, Parati E; European Moyamoya Disease Initiative: Research Progresses in Understanding the Pathophysiology of Moyamoya Disease. <i>Cerebrovasc Dis<\/i> 41: 105\u2013118, 2016","DOI":"10.1159\/000442298"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK: Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. <i>J Neurosurg<\/i> 111: 927\u2013935, 2009","DOI":"10.3171\/2009.4.JNS081649"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Fujimura M, Tominaga T: Significance of cerebral blood flow analysis in the acute stage after revascularization surgery for Moyamoya disease. <i>Neurol Med Chir (Tokyo)<\/i> 55: 775\u2013781, 2015","DOI":"10.2176\/nmc.ra.2015-0063"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bersano A, Guey S, Bedini G, Nava S, Herv\u00e9 D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJ, Braun KP, Kronenburg A, Acerbi F, Brown MM, Calviere L, Cordonnier C, Henon H, Thines L, Khan N, Czabanka M, Kraemer M, Simister R, Prontera P, Tournier-Lasserve E, Parati E; Research progresses in understanding the pathophysiology of Moyamoya disease. <i>Cerebrovasc Dis<\/i> 41: 105\u2013118, 2016","DOI":"10.1159\/000442298"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S: A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. <i>J Hum Genet<\/i> 56: 34\u201340, 2011","DOI":"10.1038\/jhg.2010.132"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A: Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. <i>PLoS One<\/i> 6: e22542, 2011","DOI":"10.1371\/journal.pone.0022542"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Mukasa A, Nakatomi H, Shimizu T, Saito N: Genetic variant RNF213 c.14576G&gt;A in various phenotypes of intracranial major artery stenosis\/occlusion. <i>Stroke<\/i> 44: 2894\u20132897, 2013","DOI":"10.1161\/STROKEAHA.113.002477"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N: Homozygous c.14576G&gt;A variant of RNF213 predicts early-onset and severe form of moyamoya disease. <i>Neurology<\/i> 78: 803\u2013810, 2012","DOI":"10.1212\/WNL.0b013e318249f71f"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/57\/2\/57_st.2016-0153\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T06:03:49Z","timestamp":1568700229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/57\/2\/57_st.2016-0153\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2176\/nmc.st.2016-0153","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}